Vantage Investment Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | $400K | Buy |
6,451
+597
| +10% | +$37K | 0.08% | 110 |
|
|
2018
Q2 | $324K | Buy |
5,854
+3
| +0.1% | +$166 | 0.08% | 113 |
|
|
2018
Q1 | $370K | Sell |
5,851
-873
| -13% | -$55.2K | 0.09% | 106 |
|
|
2017
Q4 | $412K | Buy |
6,724
+878
| +15% | +$53.8K | 0.09% | 109 |
|
|
2017
Q3 | $373K | Buy |
5,846
+3
| +0.1% | +$191 | 0.1% | 104 |
|
|
2017
Q2 | $326K | Sell |
5,843
-583
| -9% | -$32.5K | 0.09% | 105 |
|
|
2017
Q1 | $349K | Buy |
6,426
+15
| +0.2% | +$815 | 0.11% | 99 |
|
|
2016
Q4 | $375K | Sell |
6,411
-64
| -1% | -$3.74K | 0.15% | 90 |
|
|
2016
Q3 | $349K | Sell |
6,475
-40
| -0.6% | -$2.16K | 0.16% | 85 |
|
|
2016
Q2 | $477K | Buy |
6,515
+95
| +1% | +$6.96K | 0.2% | 74 |
|
|
2016
Q1 | $410K | Sell |
6,420
-197
| -3% | -$12.6K | 0.18% | 81 |
|
|
2015
Q4 | $455K | Buy |
6,617
+217
| +3% | +$14.9K | 0.23% | 72 |
|
|
2015
Q3 | $379K | Buy |
6,400
+1,938
| +43% | +$115K | 0.21% | 77 |
|
|
2015
Q2 | $297K | Sell |
4,462
-3,393
| -43% | -$226K | 0.16% | 92 |
|
|
2015
Q1 | $507K | Buy |
7,855
+4,620
| +143% | +$298K | 0.14% | 95 |
|
|
2014
Q4 | $191K | Buy |
3,235
+973
| +43% | +$57.4K | 0.11% | 114 |
|
|
2014
Q3 | $116K | Buy |
2,262
+100
| +5% | +$5.13K | 0.07% | 144 |
|
|
2014
Q2 | $105K | Hold |
2,162
| – | – | 0.06% | 159 |
|
|
2014
Q1 | $112K | Buy |
2,162
+600
| +38% | +$31.1K | 0.07% | 149 |
|
|
2013
Q4 | $83K | Buy |
+1,562
| New | +$83K | 0.06% | 171 |
|